Results
Bal Pharma Q1 FY27 Net Profit Rises to ₹8.58 Crore
Bal Pharma reported unaudited standalone Q1 FY27 net profit of ₹8.58 crore, up from ₹4.97 crore YoY.
Total income increased to ₹63.41 crore with EPS at ₹18.65 for the quarter ended June 30, 2026.
Comp
